| Product NDC: | 0069-3230 | 
| Proprietary Name: | Feldene | 
| Non Proprietary Name: | PIROXICAM | 
| Active Ingredient(s): | 20 mg/1 & nbsp; PIROXICAM | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | CAPSULE | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0069-3230 | 
| Labeler Name: | Pfizer Laboratories Div Pfizer Inc | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA018147 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 19940525 | 
| Package NDC: | 0069-3230-66 | 
| Package Description: | 100 CAPSULE in 1 BOTTLE (0069-3230-66) | 
| NDC Code | 0069-3230-66 | 
| Proprietary Name | Feldene | 
| Package Description | 100 CAPSULE in 1 BOTTLE (0069-3230-66) | 
| Product NDC | 0069-3230 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | PIROXICAM | 
| Dosage Form Name | CAPSULE | 
| Route Name | ORAL | 
| Start Marketing Date | 19940525 | 
| Marketing Category Name | NDA | 
| Labeler Name | Pfizer Laboratories Div Pfizer Inc | 
| Substance Name | PIROXICAM | 
| Strength Number | 20 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |